- A total of 47 adoptive cell relevant abstracts which can be linked to therapy or trial have been identified from the meeting and we have taken the time to present a summary of these in this post-conference report.
- We hope you found this post-conference report on the cell therapy landscape from the ASGCT 2022 Annual Meeting useful and insightful.
Find out more
This insight and data is part of the subscription to Beacon Adoptive Cell.
Speak with our Team
Our dedicated team can help you with questions by showing you how this insight and data is collated on Beacon.
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements